Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying carcinoma risk.

[1]  M. Armstrong,et al.  Complex Atypical Endometrial Hyperplasia: The Risk of Unrecognized Adenocarcinoma and Value of Preoperative Dilation and Curettage , 2009, Obstetrics and gynecology.

[2]  J. Manson,et al.  Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study , 2009, Obstetrics and gynecology.

[3]  J. Palazzo,et al.  Presence of endometrial adenocarcinoma in situ in complex atypical endometrial hyperplasia is associated with increased incidence of endometrial carcinoma in subsequent hysterectomy , 2009, Modern Pathology.

[4]  R. Barakat,et al.  Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma. , 2008, Gynecologic oncology.

[5]  G. Maxwell,et al.  The ability of endometrial biopsies with atypical complex hyperplasia to guide surgical management. , 2008, American journal of obstetrics and gynecology.

[6]  K. Mittal,et al.  Endometrial Hyperplasia and Carcinoma in Endometrial Polyps: Clinicopathologic and Follow-Up Findings , 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[7]  D. Levine,et al.  The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology , 2007, International Journal of Gynecologic Cancer.

[8]  R. Barakat,et al.  The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. , 2006, Gynecologic oncology.

[9]  R. Zaino,et al.  Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia , 2006, Cancer.

[10]  R. Zaino,et al.  Reproducibility of the diagnosis of atypical endometrial hyperplasia , 2006, Cancer.

[11]  T. Wright,et al.  Prevalence of Underlying Adenocarcinoma in Women with Atypical Endometrial Hyperplasia , 2005, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[12]  P. V. van Diest,et al.  The molecular genetics and morphometry‐based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system , 2005, Cancer.

[13]  J. Baak,et al.  Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis , 2005, Modern Pathology.

[14]  K. Mittal,et al.  Endometrial Adenocarcinoma in Situ in Complex Atypical Hyperplasia: Correlation with Findings in Subsequent Hysterectomy Specimen , 2004, International journal of surgical pathology.

[15]  M. J. Webb,et al.  Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? , 2000, American journal of obstetrics and gynecology.

[16]  C. Perez,et al.  Principles and Practice of Gynecologic Oncology , 1992 .

[17]  R. Kurman,et al.  Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study , 1991 .

[18]  B. Bundy,et al.  Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.

[19]  R. Kurman,et al.  The behavior of endometrial hyperplasia. A long‐term study of “untreated” hyperplasia in 170 patients , 1985 .

[20]  R. Kurman,et al.  Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well‐differentiated carcinoma , 1982 .